North America
Wall St. lower but finishes year with solid gains
U.S. stocks fell on Wednesday as crude oil prices continued their descent, but the S&P closed out a third straight year of double-digit gains.
NeuroDerm shares double as Parkinson's drug shows promise
NeuroDerm Ltd's shares more than doubled in value on Tuesday, after the company said data from a mid-stage study suggested that a higher dose of its Parkinson's drug could provide an alternative to treatments that require surgery.
FDA approves Roche Ebola test for emergency use
Roche Holding AG said U.S. health regulators have approved its Ebola test for emergency use in response to the world's worst outbreak of the disease in West Africa
After 2014's party, investors in U.S. stock market may face a hangover
Revelers ringing in of the new year this week need to watch out for the next day's hangover. And investors may experience a similar feeling early in 2015 after a two-year run that has propelled U.S. stocks up by nearly 50 percent.